ApoE4: Is it the absence of good or the presence of bad?

Journal of Alzheimer's Disease

Volumn 4, Issue 3, 2002, Pages 141-143

  Ashford, J Wesson ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CHOLESTEROL; TAU PROTEIN;

ALZHEIMER DISEASE; COGNITION; CYTOSKELETON; HUMAN; NERVE CELL PLASTICITY; NEURITE; NEUROPATHOLOGY; NEUROPROTECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; SHORT SURVEY;

EID: 0036592797     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2002-4303     Document Type: Short Survey

References (3)

1. Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: Evidence that simvastatin affects cholesterol metabolism in the human brain
2. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people
3. Serum lipoprotein levels, statin use, and cognitive function in older women